Want to see ZTS full AI Analyst Report?

Zoetis (ZTS) Stock Forecast & Price Target

3,957 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZTS Analyst Ratings

Moderate Buy

5 Buy

6 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Zoetis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZTS Stock 12 Month Forecast

Average Price Target

$104.75

▼(-14.41% Downside)

Based on 11 Wall Street analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is $104.75 with a high forecast of $130.00 and a low forecast of $85.00. The average price target represents a -14.41% change from the last price of $122.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","114":"$114","157":"$157","92.5":"$92.5","135.5":"$135.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$130.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$104.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$85.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,92.5,114,135.5,157],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.45,76.87692307692308,81.30384615384615,85.73076923076923,90.15769230769232,94.58461538461538,99.01153846153846,103.43846153846154,107.86538461538461,112.29230769230769,116.71923076923076,121.14615384615385,125.57307692307691,{"y":130,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.45,74.93461538461538,77.41923076923077,79.90384615384616,82.38846153846154,84.87307692307692,87.3576923076923,89.84230769230768,92.32692307692308,94.81153846153846,97.29615384615384,99.78076923076924,102.26538461538462,{"y":104.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.45,73.41538461538462,74.38076923076923,75.34615384615385,76.31153846153846,77.27692307692308,78.24230769230769,79.20769230769231,80.17307692307692,81.13846153846154,82.10384615384615,83.06923076923077,84.03461538461539,{"y":85,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":156.754,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.61,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":154.522,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.185,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.855,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.16,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.742,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.398,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.401,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.782,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.16,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.56,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.45,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$130.00

Average Price Target$104.75

Lowest Price Target$85.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Glen Santangelo

Barclays

$85

Hold

-30.54%

Downside

Reiterated

07/01/26

Barclays Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

$150→$104

Buy

-15.02%

Downside

Assigned

06/30/26

Zoetis: Buy Rating Reaffirmed as Analyst Cuts Target to $104 but Sees Undervalued Long-Term Growth

Jonathan Block

Stifel Nicolaus

$95→$85

Hold

-30.54%

Downside

Assigned

06/26/26

Zoetis price target lowered to $85 from $95 at StifelZoetis price target lowered to $85 from $95 at Stifel

Michael Ryskin

Bank of America Securities

$108

Hold

-11.75%

Downside

Reiterated

06/16/26

Zoetis Kept at Hold as Competitive Pressures Mount and Innovation Lags; Price Target Maintained at $108

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Jasper Hellweg

Argus Research

―

Hold

―

Downgraded

05/26/26

Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus

Daniel Grosslight

Citi

$145→$112

Buy

-8.48%

Downside

Reiterated

05/18/26

Zoetis price target lowered to $112 from $145 at CitiZoetis price target lowered to $112 from $145 at Citi

Erin Wright

Morgan Stanley

$115

Buy

-6.03%

Downside

Assigned

05/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Zoetis (NYSE: ZTS), Sarepta Therapeutics (NASDAQ: SRPT) and GoodRx Holdings (NASDAQ: GDRX)

Chris Schott

J.P. Morgan

$190→$130

Buy

6.23%

Upside

Assigned

05/08/26

Zoetis price target lowered to $130 from $190 at JPMorganZoetis price target lowered to $130 from $190 at JPMorgan

Andrea Alfonso

UBS

$130→$99

Hold

-19.10%

Downside

Reiterated

05/08/26

Zoetis price target lowered to $99 from $130 at UBSZoetis price target lowered to $99 from $130 at UBS

Scott Schoenhaus

KeyBanc

―

Hold

―

Reiterated

05/08/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)

Sidharth Sahoo

HSBC

$120.49→$140

Buy

14.40%

Upside

Reiterated

03/10/26

Thomas DeBourcy

Nephron

$131

Hold

7.04%

Upside

Downgraded

03/05/26

Zoetis downgraded to Hold from Buy at Nephron ResearchZoetis downgraded to Hold from Buy at Nephron Research

Mark Massaro

BTIG

$160

Buy

30.74%

Upside

Reiterated

02/26/26

Zoetis (ZTS) Receives a Buy from BTIG

David Westenberg

Piper Sandler

$190→$135

Hold

10.31%

Upside

Downgraded

01/22/26

Zoetis downgraded to Neutral from Overweight at Piper SandlerZoetis downgraded to Neutral from Overweight at Piper Sandler

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Glen Santangelo

Barclays

$85

Hold

-30.54%

Downside

Reiterated

07/01/26

Barclays Sticks to Its Hold Rating for Zoetis (ZTS)

Steve Scala

TD Cowen

$150→$104

Buy

-15.02%

Downside

Assigned

06/30/26

Zoetis: Buy Rating Reaffirmed as Analyst Cuts Target to $104 but Sees Undervalued Long-Term Growth

Jonathan Block

Stifel Nicolaus

$95→$85

Hold

-30.54%

Downside

Assigned

06/26/26

Zoetis price target lowered to $85 from $95 at StifelZoetis price target lowered to $85 from $95 at Stifel

Michael Ryskin

Bank of America Securities

$108

Hold

-11.75%

Downside

Reiterated

06/16/26

Zoetis Kept at Hold as Competitive Pressures Mount and Innovation Lags; Price Target Maintained at $108

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

06/03/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Jasper Hellweg

Argus Research

―

Hold

―

Downgraded

05/26/26

Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus

Daniel Grosslight

Citi

$145→$112

Buy

-8.48%

Downside

Reiterated

05/18/26

Zoetis price target lowered to $112 from $145 at CitiZoetis price target lowered to $112 from $145 at Citi

Erin Wright

Morgan Stanley

$115

Buy

-6.03%

Downside

Assigned

05/15/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Zoetis (NYSE: ZTS), Sarepta Therapeutics (NASDAQ: SRPT) and GoodRx Holdings (NASDAQ: GDRX)

Chris Schott

J.P. Morgan

$190→$130

Buy

6.23%

Upside

Assigned

05/08/26

Zoetis price target lowered to $130 from $190 at JPMorganZoetis price target lowered to $130 from $190 at JPMorgan

Andrea Alfonso

UBS

$130→$99

Hold

-19.10%

Downside

Reiterated

05/08/26

Zoetis price target lowered to $99 from $130 at UBSZoetis price target lowered to $99 from $130 at UBS

Scott Schoenhaus

KeyBanc

―

Hold

―

Reiterated

05/08/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Evolent Health (NYSE: EVH), Zoetis (NYSE: ZTS) and ICU Medical (NASDAQ: ICUI)

Sidharth Sahoo

HSBC

$120.49→$140

Buy

14.40%

Upside

Reiterated

03/10/26

Thomas DeBourcy

Nephron

$131

Hold

7.04%

Upside

Downgraded

03/05/26

Zoetis downgraded to Hold from Buy at Nephron ResearchZoetis downgraded to Hold from Buy at Nephron Research

Mark Massaro

BTIG

$160

Buy

30.74%

Upside

Reiterated

02/26/26

Zoetis (ZTS) Receives a Buy from BTIG

David Westenberg

Piper Sandler

$190→$135

Hold

10.31%

Upside

Downgraded

01/22/26

Zoetis downgraded to Neutral from Overweight at Piper SandlerZoetis downgraded to Neutral from Overweight at Piper Sandler

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zoetis

3 Months

Steve ScalaTD Cowen

Success Rate

10/19 ratings generated profit

Average Return

-2.73%

Copying Steve Scala's trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of -2.73% per trade.

1 Year

Erin WrightMorgan Stanley

Success Rate

11/23 ratings generated profit

Average Return

-1.31%

Copying Erin Wright's trades and holding each position for 1 Year would result in 47.83% of your transactions generating a profit, with an average return of -1.31% per trade.

2 Years

Steve ScalaTD Cowen

Success Rate

9/19 ratings generated profit

Average Return

+4.93%

Copying Steve Scala's trades and holding each position for 2 Years would result in 47.37% of your transactions generating a profit, with an average return of +4.93% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZTS Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZTS has received 7 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. ZTS average Analyst price target in the past 3 months is 104.75.

Each month's total comprises the sum of three months' worth of ratings.

ZTS Financial Forecast

ZTS Earnings Forecast

Next quarter’s earnings estimate for ZTS is $1.86 with a range of $1.77 to $1.96. The previous quarter’s EPS was $1.53. ZTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ZTS has Performed in-line its overall industry.

ZTS Sales Forecast

Next quarter’s sales forecast for ZTS is $2.51B with a range of $2.44B to $2.56B. The previous quarter’s sales results were $2.26B. ZTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ZTS has Performed in-line its overall industry.

ZTS Stock Forecast FAQ

What is ZTS’s average 12-month price target, according to analysts?

Based on analyst ratings, Zoetis’s 12-month average price target is 104.75.

What is ZTS’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for ZTS, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ZTS a Buy, Sell or Hold?

Zoetis has a consensus rating of Moderate Buy which is based on 5 buy ratings, 6 hold ratings and 0 sell ratings.

What is Zoetis’s price target?

The average price target for Zoetis is 104.75. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $130.00 ,the lowest forecast is $85.00. The average price target represents -14.41% Decrease from the current price of $122.38.

What do analysts say about Zoetis?

Zoetis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of ZTS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Zoetis (ZTS) Stock Forecast & Price Target

ZTS Analyst Ratings

ZTS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zoetis

ZTS Analyst Recommendation Trends

ZTS Financial Forecast

ZTS Earnings Forecast

ZTS Sales Forecast

ZTS Stock Forecast FAQ

Detailed List of Analyst Forecasts